CAVA Group Inc vs Inovio Pharmaceuticals Inc — how do they compare? CAVA Group Inc trades at $67.73 (market cap $7.08B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: CAVA Group Inc is far larger — about 90.1× Inovio Pharmaceuticals Inc's market cap, and CAVA Group Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CAVA | INO | |
|---|---|---|
Market Cap | $7.08B | $78.55M |
Sector | Consumer Cyclical | Health |
52-Week High | $97.39 | $2.87 |
52-Week Low | $43.59 | $0.66 |
Enterprise Value | $7.23B | $49.56M |
Trailing returns across standard periods
Latest headlines on both assets
CAVA is a Mediterranean fast-casual restaurant brand in the US. It offers customizable bowls, salads, and pitas featuring healthy ingredients, while also selling its signature dips and dressings in grocery stores.
Read more on CAVA →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →